45 calendar days
The clock begins after the decision owner, access, materials, permissions, and agreement are confirmed.
Innovation LabsBring us the decision
The 45-Day Innovation Verification Sprint
Build and test the first working form of one consequential health model in 45 days.
FHIL turns one bounded health model into a working MVP that at least one intended user or accountable operator uses, one complete pathway carries, and your institution can inspect, share, and test.
The evidence and decision record includes an Institutional Decision Gate Report and implementation blueprint: a documented basis for whether to proceed, proceed with conditions, redesign, test further, or stop.
The test stays bounded. Current services, clinical responsibilities, governance, and institutional authority remain in place. The Sprint does not prove scale or guarantee outcomes.
Engagement facts
Engagement facts
One innovation
Up to two linked decisions when they share the same setting, evidence, and operating model.
One person. One pathway. One setting.
The smallest usable form, used by at least one intended user or accountable operator and tested against real operating conditions.
An MVP, governance and data model, and decision record
A First Operating Form, the information and decision rules around it, one recommendation for each decision in scope, and one integrated next-action plan.
Evidence in the work
Commissioned research. A paid technology build.
Agora and ATLAS show work that informs this offer. Neither case is presented as proof that every Sprint produces the same result.
Agora
Research findings and systems maps made community mental-health roles and referral gaps visible for a foundation's further planning.
ATLAS Rare Disease
An AI-assisted patient on-ramp and knowledge base. The buyer funded two stages and paused further work based on the findings.
These commissions establish delivered work, not clinical effectiveness, sustained adoption, or a repeatable result across customers. Agora's research is not a completed clinical pilot.
Strong fit
Use the Sprint when delay is costly—but unsupported speed is unacceptable.
The Sprint is ready to begin when the decision, deadline, uncertainty, and access are real.
- A named owner must fund, authorize, adopt, launch, partner, scale, redesign, or stop.
- The decision has a real deadline and material uncertainty about safety, workflow, governance, evidence, or implementation.
- The innovation has promise, but the institution does not yet know whether it fits the target population and setting.
- The sponsor can authorize the evidence, people, workflow, and bounded use needed to build and test the first operating form responsibly.
How the 45 days work
Frame. Observe. Build and test. Compare. Decide.
The work starts with the institution’s decision and gives the ambition its first usable form.
- Days 1–5
Frame
Agree on the decision, owner, deadline, target setting, evidence threshold, access, and the assumptions most likely to change the answer.
Buyer-visible milestoneDecision frame and evidence plan
- Days 6–15
Observe
Identify the task and where it breaks down. Use authorized interviews, observation, mapping, document review, or existing data. Check whether the barrier is information, workflow, access, or something the proposed tool cannot resolve.
Buyer-visible milestoneSystem map and prioritized risks
- Days 16–30
Build and test
Build or configure the smallest working form for one complete pathway. Use existing tools where they meet the need. Test the agreed task with at least one intended user or accountable operator, within the agreed safeguards.
Buyer-visible milestoneWorking MVP used in one bounded setting
- Days 31–40
Compare
Compare the working form with the current approach against agreed task checks. Record completion, corrections, human effort, and unresolved risks where observable. State what the comparison cannot establish.
Buyer-visible milestoneTested operating form, draft recommendation, and blueprint
- Days 41–45
Decide
Hand over the MVP, evidence, recommendation, and next-action plan. Identify who would operate it, what support it needs, and the costs and responsibilities that remain before continued use.
Buyer-visible milestoneWorking MVP, Decision Gate Report, and handover
After Day 45: The client receives the decision record and may implement independently, commission another provider, or ask FHIL to scope further support. No continuation is assumed.
Authorized access to at least one intended user or accountable operator is required before Day 1. Any additional direct workflow or user evidence is gathered only when it is material, safe, lawful, and authorized; limitations remain visible in the recommendation.
What you receive
A working MVP and the record needed to decide what comes next.
The operating form changes with the mandate. The requirement that it be usable and inspectable does not.
Working MVP · First Operating Form
A usable version of the ambition that at least one intended user or accountable operator has used, one complete pathway can carry, and the institution can inspect, share, and test. The form may be software, a service pathway, a workflow, a field tool, a protocol, or a decision interface.
Governance and data model
Who decides, what safeguards apply, which data sources must connect, and what the analysis must reveal about supply, demand, access, capacity, and friction. Where relevant, the model may specify shortage heat maps, drive-time coverage, capacity forecasts, or scenario simulations.
Evidence and decision record
An Institutional Decision Gate Report documenting the decision, evidence threshold, sources, findings, risks, limitations, open questions, and recommendation. It includes an implementation blueprint setting out the roles, workflow, safeguards, evidence needs, dependencies, checkpoints, and reassessment triggers for the next commitment.
What the recommendation can say
A recorded judgment—not a stamp of certainty.
FHIL compares the proposed innovation with the evidence and real operating conditions the decision depends on. Facts, interpretation, unknowns, and recommendations remain visible.
Proceed
The available evidence supports the proposed next commitment within the reviewed scope.
Proceed with conditions
The commitment is supportable only if named safeguards, limits, or dependencies are satisfied.
Redesign
A material part of the model does not fit the target setting and should change before further commitment.
Test further
A defined additional test could resolve uncertainty that still prevents a responsible commitment.
Stop
The available evidence does not support continued commitment to the reviewed model or conditions.
Buyer readiness
The clock begins when the decision, access, and bounded test are ready.
Before Day 1, FHIL and the sponsor confirm six conditions.
01
Six readiness gates
- A named decision owner with authority to sponsor the work.
- One innovation and no more than two genuinely linked decisions.
- A defined decision date and agreed evidence threshold.
- Access to the relevant evidence, people, workflow, and operating conditions.
- Authorized access to at least one intended user or accountable operator, plus authority to build and test one narrow operating form through one complete pathway.
- The permissions required to examine the priority assumptions responsibly.
02
Participation
The decision owner reserves one 60–90 minute weekly review, names an operational contact, and helps resolve material access or permission questions promptly. The Sprint is hybrid by default and may combine remote analysis, interviews, working sessions, on-site observation, and bounded testing.
Pricing is confirmed after the readiness review. Travel, external specialists, and third-party expenses are identified separately.
Clear boundaries
FHIL builds the MVP and supports the decision. Your institution retains its authority.
The Sprint includes a narrow working MVP, not full-scale deployment, rollout, integration, or ongoing operations. It does not certify the innovation, guarantee outcomes, replace licensed or institutional authorities, or raise capital.
The client receives
The working MVP and the agreed evidence, maps, workflows, recommendations, and blueprint. The client retains ownership of its data.
FHIL retains
Its pre-existing methods, templates, tools, software components, and know-how, subject to the engagement agreement.
Authorities retain
Clinical, legal, regulatory, ethics, security, procurement, data, funding, and institutional approval responsibilities.
Confidentiality remains explicit
FHIL does not identify the client or publish engagement material without written permission.
After capital is committed
Reviewing several initiatives already funded?
The 45-Day Sprint verifies one innovation before a larger commitment. The Portfolio Verification Review compares funded promises with documented delivery and portfolio learning before the next allocation.
See the Portfolio Verification ReviewBegin a conversation
Bring the decision before the larger commitment narrows your options.
Tell us what the institution is considering, what must keep working, where the innovation must work, and when the decision is due.
Do not include patient-identifiable, protected, classified, privileged, or institution-confidential information in the initial message.
Discuss a Verification Sprint Or write directly to victorladele@fhilabs.com.